JONATHAN J. PEHRSON, M.D.; JUDITH VAITUKAITIS, M.D.; CHRISTOPHER LONGCOPE, M.D.
This content is PDF only. Please click on the PDF icon to access.
Polycystic ovary syndrome is one of the commonest endocrinologic disorders of reproduction, and the disorder probably reflects a primary hypothalamic defect resulting in altered patterns of gonadotropin and prolactin secretion (1). Women usually present during their early reproductive years with various degrees and combinations of menstrual dysfunction and with signs of androgen excess and polycystic ovaries. The wide spectrum of clinical and biochemical abnormalities is presumably the result of differences in severity and duration of the syndrome, sex steroid metabolism, and end-organ sensitivities.
The characteristic polycystic ovary contains numerous follicular cysts in varied stages of development and atresia, surrounded by
PEHRSON JJ, VAITUKAITIS J, LONGCOPE C. Bromocriptine, Sex Steroid Metabolism, and Menstrual Patterns in the Polycystic Ovary
Syndrome. Ann Intern Med. 1986;105:129–130. doi: https://doi.org/10.7326/0003-4819-105-1-129
Download citation file:
Published: Ann Intern Med. 1986;105(1):129-130.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use